Home/Filings/4/0001179110-17-010594
4//SEC Filing

Paull Robert Bradley 4

Accession 0001179110-17-010594

CIK 0001479419other

Filed

Jul 20, 8:00 PM ET

Accepted

Jul 21, 4:20 PM ET

Size

5.4 KB

Accession

0001179110-17-010594

Insider Transaction Report

Form 4
Period: 2017-07-19
Paull Robert Bradley
Director10% Owner
Transactions
  • Award

    Stock Option (right to buy)

    2017-07-19+12,96012,960 total
    Exercise: $15.00Exp: 2027-07-18Common Stock (12,960 underlying)
Footnotes (1)
  • [F1]This option was granted, effective on July 19, 2017 and vests over one year, with 8.33% of the shares underlying the option vesting on August 19, 2017, and an addition 8.33% of the shares underlying the option vesting at the end of each successive one-month period thereafter.

Issuer

Kala Pharmaceuticals, Inc.

CIK 0001479419

Entity typeother

Related Parties

1
  • filerCIK 0001711254

Filing Metadata

Form type
4
Filed
Jul 20, 8:00 PM ET
Accepted
Jul 21, 4:20 PM ET
Size
5.4 KB